Navigation Links
Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R)
Date:10/13/2009

DALLAS, Oct. 13 /PRNewswire/ -- Eclipsemed Ltd, a leading national supplier of advanced medical and aesthetic equipment, has announced its recent partnership with Human Med USA. Human Med AG of Germany, a leading manufacturer of medical and aesthetic devices including the revolutionary Body-Jet®, has formed Human Med USA to partner with Eclipse to increase efforts to sell Body-Jet® in the United States and North America.

"With the exceptionally strong sales advancement of Body-Jet in the United States, Human Med saw an opportunity to further support this unprecedented growth. By forming a partnership alliance to enhance the Eclipse effort, we believe this team concept shall be a supportive foundation for the significant increase in projected revenue," says Arnd Kensy, CEO Human Med AG.

Tom O'Brien, CEO Eclipsemed adds, "Human Med's willingness to create a US subsidiary to support our explosive growth is an indicator of their confidence in the Body-Jet's future and the Eclipse rapid market penetration. Opportunities to transform an entire market in a short time are usually rare events. Together such an opportunity will certainly be realized."

About Eclipsemed Ltd.

Eclipse is a leading supplier of aesthetic high-tech medical devices and related products. Eclipse has established a reputation as a trend setter on the national aesthetic market scene. The recent launch of the Body-Jet, water jet assisted liposuction technology is the most current example of how Eclipse has established itself as a undeniable force in bringing innovative products to market. Through its own direct sales force and team of independent agents, Eclipse continues to introduce products and solutions to the aesthetic marketplace. www.eclipsemed.com

About Human Med AG

Human Med is a leading manufacturer of medical and aesthetic devices that minimize surgery time as well as recovery periods. Human Med has gained international notoriety with the revolutionary Body-Jet®. They continue to seek a stronger cooperation with product users in order to develop new applications for water jet technology and to break into additional disciplines of medicine.

SOURCE Eclipsemed Ltd.


'/>"/>
SOURCE Eclipsemed Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” ... adults with muscular dystrophy, ALS and related diseases that severely limit strength and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
Breaking Medicine News(10 mins):